Please watch or read about some of our highlights in 2021.
Looking back at 2021, the first full year of MainlyAI operation, we would like to express our gratitude to our employees, partners, and investors for their contribution to help us approach our vision – To turn data into knowledge and actions, using artificial intelligence.
In 2021, we strengthened the development team that now has competences ranging over UX, data science, AI modelling, database design, and cloud computing. Many thanks for your solid contribution to developing our MIRANDA platform – it is constantly evolving, and today we are ready to show the world its capacity and unique features.
Our already strong project portfolio has been extended with an innovation milleu funded by the Swedish innovation agency, Vinnova, that will benefit those risking to be affected by Diabetes type I and, in the longer run, other auto-immune diseases. We look forward to collaborating in a partner constellation consisting of Diamyd Medical, Leading Health Care, Lund University, National Diabetes Register, and Sahlgrenska University Hospital. The project, named AI for Sustainable Prevention of Autoimmunity in the Society (ASSET), will run over five years with a total budget of 60 MSEK.
We received support from KTH Innovation, and upon completion of the KTH pre-incubator program we partnered up with Busybee, a Stockholm based tech startup that offers occupancy detection systems and venue management to businesses. Finally, we would like to extend a special thanks to our growing network of partners: Astra Zeneca, Busybee, Diamyd Medical, Hitachi ABB, KTH, Leading Health Care, Lund University, National Diabetes Registry, Sahlgrenska University Hospital, Scania, Seco Tools, and Uppsala University.